Salmaan Khan

1.2k total citations
22 papers, 935 citations indexed

About

Salmaan Khan is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Salmaan Khan has authored 22 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Physiology and 5 papers in Surgery. Recurrent topics in Salmaan Khan's work include Adipose Tissue and Metabolism (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Pancreatic function and diabetes (5 papers). Salmaan Khan is often cited by papers focused on Adipose Tissue and Metabolism (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Pancreatic function and diabetes (5 papers). Salmaan Khan collaborates with scholars based in United States, United Kingdom and Russia. Salmaan Khan's co-authors include Douglas G. Mashek, Alex J. Lange, Aishwarya Sathyanarayan, Mara T. Mashek, Chaodong Wu, Kuok Teong Ong, Bhanu Chandra Mulukutla, Wei‐Shou Hu, Honggui Li and Todd W. Markowski and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Cell and Hepatology.

In The Last Decade

Salmaan Khan

20 papers receiving 911 citations

Peers

Countries citing papers authored by Salmaan Khan

Since Specialization

Citations

This map shows the geographic impact of Salmaan Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salmaan Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salmaan Khan more than expected).

Fields of papers citing papers by Salmaan Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salmaan Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salmaan Khan. The network helps show where Salmaan Khan may publish in the future.

Co-authorship network of co-authors of Salmaan Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Salmaan Khan. A scholar is included among the top collaborators of Salmaan Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salmaan Khan. Salmaan Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessments of prostate cancer cell functions highlight differences between a pan‐ PI 3 K /m TOR inhibitor, gedatolisib, and single‐node inhibitors of the PI 3 K / AKT /m TOR pathway 2024 ·Molecular Oncology ·(unknown), Salmaan Khan, Stefano Rossetti, (unknown), Ian A. MacNeil, Ann DeLaForest, (unknown), Laura I. Davis, (unknown), (unknown), Ross A. Kopher, Stephen Schulz, Lance Laing	4
2	Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models 2024 ·npj Breast Cancer ·Stefano Rossetti, (unknown), (unknown), Salmaan Khan, Ian A. MacNeil, (unknown), Ross A. Kopher, Stephen Schulz, Lance Laing	14
3	Therapeutic effect of gedatolisib, a pan-PI3K/mTOR inhibitor, on prostate cancer models with PI3K or PTEN mutational status. 2023 ·Journal of Clinical Oncology ·Adrish Sen, Salmaan Khan, Ian A. MacNeil, Benjamin E. Rich, (unknown), (unknown), Stefano Rossetti, (unknown), Lance Laing	2
4	Functional signaling test identifies HER2 negative breast cancer patients who may benefit from c-Met and pan-HER combination therapy 2022 ·Cell Communication and Signaling ·Ian A. MacNeil, Salmaan Khan, (unknown), Sajjad Soltani, David J. Burns, (unknown), Lance Laing	2
5	Abstract 342: Sub-group of HER2-negative breast cancer patients with hyperactive RAS network signaling identified: Dynamic pathway activity test identifies patients that may benefit from PI3K/mTOR or PI3K/mTOR/BCL inhibitors 2021 ·Cancer Research ·Salmaan Khan, (unknown), (unknown), Ian A. MacNeil, (unknown), Sarah C. Mutka, (unknown), (unknown), Laura Milligan, (unknown), (unknown), Lance Laing	2
6	Abstract 367: Sub-group of ovarian cancer patients with hyperactive RAS network signaling identified: Dynamic pathway activity test identifies patients that may benefit from PI3K/mTOR or PI3K/mTOR/BCL inhibitors 2021 ·Cancer Research ·Stefano Rossetti, (unknown), (unknown), Shu Z. Wiley, Salmaan Khan, (unknown), Ian A. MacNeil, (unknown), Lance Laing	1
7	Test identifies ovarian cancer patients with hyperactive c-Met and ErbB signaling tumors who may benefit from c-Met and pan-HER combination therapy. 2020 ·Journal of Clinical Oncology ·Lance Laing, Stefano Rossetti, (unknown), (unknown), (unknown), Salmaan Khan, Ian A. MacNeil, (unknown)	1
8	Lipid Droplet-Derived Monounsaturated Fatty Acids Traffic via PLIN5 to Allosterically Activate SIRT1 2019 ·Molecular Cell ·Charles P. Najt, Salmaan Khan, Timothy D. Heden, Bruce A. Witthuhn, (unknown), (unknown), (unknown), (unknown), Kenneth K. Karanja, Mark J. Graham, Mara T. Mashek, David Bernlohr, Laurie L. Parker, Lisa S. Chow, Douglas G. Mashek	119
9	Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins 2016 ·Cell Reports ·Wenwei Zhang, So Young Bu, Mara T. Mashek, InSug O‐Sullivan, (unknown), Salmaan Khan, Olga Ilkayeva, Christopher B. Newgard, Douglas G. Mashek, Terry G. Unterman	65
10	Quantitative analysis of the murine lipid droplet-associated proteome during diet-induced hepatic steatosis 2015 ·Journal of Lipid Research ·Salmaan Khan, (unknown), Todd W. Markowski, LeeAnn Higgins, Douglas G. Mashek	57
11	ATGL‐catalyzed lipolysis regulates SIRT1 to control PGC‐1 a /PPAR‐ a signaling 2015 ·The FASEB Journal ·Aishwarya Sathyanarayan, Salmaan Khan, Mara T. Mashek, Douglas G. Mashek	1
12	ATGL-Catalyzed Lipolysis Regulates SIRT1 to Control PGC-1α/PPAR-α Signaling 2015 ·Diabetes ·Salmaan Khan, Aishwarya Sathyanarayan, Mara T. Mashek, Kuok Teong Ong, (unknown), Douglas G. Mashek	156
13	Recession, Plant Closures, and Older Racialized Immigrant Workers: A case study of the workers of Progressive Moulded Products An Immigrant All Over Again ? 2013 ·(unknown), Aparna Sundar, (unknown), Sedef Arat-Koç, Salmaan Khan, (unknown)	1
14	Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways 2010 ·Trends in biotechnology ·Bhanu Chandra Mulukutla, Salmaan Khan, Alex J. Lange, Wei‐Shou Hu	99
15	Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2008 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Mohammed Hasan Mukhtar, Victoria A. Payne, Catherine Arden, Andrew Harbottle, Salmaan Khan, Alex J. Lange, Loranne Agius	30
16	A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic β-cells 2008 ·Biochemical Journal ·Catherine Arden, (unknown), Guo Huang, James Shaw, A Aldibbiat, (unknown), Derek Manas, Salmaan Khan, (unknown), Loranne Agius	34
17	Roles for fructose-2,6-bisphosphate in the control of fuel metabolism: Beyond its allosteric effects on glycolytic and gluconeogenic enzymes 2006 ·Advances in Enzyme Regulation ·Chaodong Wu, Salmaan Khan, (unknown), Alex J. Lange	52
18	Perturbation of glucose flux in the liver by decreasing F26P₂levels causes hepatic insulin resistance and hyperglycemia 2006 ·American Journal of Physiology-Endocrinology and Metabolism ·Chaodong Wu, Salmaan Khan, (unknown), Honggui Li, Steven G. Carmella, Alex J. Lange	27
19	Enhancing hepatic glycolysis reduces obesity: Differential effects on lipogenesis depend on site of glycolytic modulation 2005 ·Cell Metabolism ·Chaodong Wu, Johnthomas Kang, (unknown), Honggui Li, Salmaan Khan, Christopher Hillard, David A. Okar, Alex J. Lange	82
20	Regulation of glycolysis—role of insulin 2005 ·Experimental Gerontology ·Chaodong Wu, Salmaan Khan, Alex J. Lange	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact